Molecular model of the outward facing state of the human P-glycoprotein (ABCB1), and comparison to a model of the human MRP5 (ABCC5)

[1]  L. Naesens,et al.  Role of MRP4 and MRP5 in biology and chemotherapy , 2008, AAPS PharmSci.

[2]  P. Borst,et al.  Multidrug resistance-associated proteins 3, 4, and 5 , 2007, Pflügers Archiv - European Journal of Physiology.

[3]  Clifford A Goudey,et al.  Aquaculture in Offshore Zones , 2006, Science.

[4]  A. Ravna,et al.  A homology model of SERT based on the LeuT(Aa) template. , 2006, Bioorganic & medicinal chemistry letters.

[5]  Harel Weinstein,et al.  A Comprehensive Structure-Based Alignment of Prokaryotic and Eukaryotic Neurotransmitter/Na+ Symporters (NSS) Aids in the Use of the LeuT Structure to Probe NSS Structure and Function , 2006, Molecular Pharmacology.

[6]  D. Clarke,et al.  Transmembrane segment 7 of human P-glycoprotein forms part of the drug-binding pocket. , 2006, The Biochemical journal.

[7]  R. Dawson,et al.  Structure of a bacterial multidrug ABC transporter , 2006, Nature.

[8]  D. Clarke,et al.  Transmembrane segment 1 of human P-glycoprotein contributes to the drug-binding pocket. , 2006, The Biochemical journal.

[9]  M. Prévost,et al.  Predicting the three‐dimensional structure of human P‐glycoprotein in absence of ATP by computational techniques embodying crosslinking data: Insight into the mechanism of ligand migration and binding sites , 2006, Proteins.

[10]  Lutz Schmitt,et al.  The motor domains of ABC-transporters. What can structures tell us? , 2006, Naunyn-Schmiedeberg's archives of pharmacology.

[11]  Lutz Schmitt,et al.  The motor domains of ABC-transporters , 2006, Naunyn-Schmiedeberg's Archives of Pharmacology.

[12]  D. Clarke,et al.  Recent Progress in Understanding the Mechanism of P-Glycoprotein-mediated Drug Efflux , 2005, The Journal of Membrane Biology.

[13]  S. Cole,et al.  Multidrug resistance proteins: role of P-glycoprotein, MRP1, MRP2, and BCRP (ABCG2) in tissue defense. , 2005, Toxicology and applied pharmacology.

[14]  C. Higgins,et al.  Three-dimensional Structure of P-glycoprotein , 2005, Journal of Biological Chemistry.

[15]  M. Kanehisa,et al.  The evolutionary repertoires of the eukaryotic-type ABC transporters in terms of the phylogeny of ATP-binding domains in eukaryotes and prokaryotes. , 2004, Molecular biology and evolution.

[16]  L. Doyle,et al.  Mining our ABCs: pharmacogenomic approach for evaluating transporter function in cancer drug resistance. , 2004, Cancer cell.

[17]  D. Clarke,et al.  Val133 and Cys137 in Transmembrane Segment 2 Are Close to Arg935 and Gly939 in Transmembrane Segment 11 of Human P-glycoprotein* , 2004, Journal of Biological Chemistry.

[18]  D. Clarke,et al.  Disulfide Cross-linking Analysis Shows That Transmembrane Segments 5 and 8 of Human P-glycoprotein Are Close Together on the Cytoplasmic Side of the Membrane* , 2004, Journal of Biological Chemistry.

[19]  D. Clarke,et al.  Methanethiosulfonate Derivatives of Rhodamine and Verapamil Activate Human P-glycoprotein at Different Sites* , 2003, Journal of Biological Chemistry.

[20]  K. Linton,et al.  An atomic detail model for the human ATP binding cassette transporter P‐glycoprotein derived from disulphide cross‐ linking and homology modeling , 2003, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[21]  H. V. van Veen,et al.  A new dimer interface for an ABC transporter. , 2003, International journal of antimicrobial agents.

[22]  A. Garnier-Suillerot,et al.  A Structural Model for the Open Conformation of the mdr1 P-glycoprotein Based on the MsbA Crystal Structure* , 2003, Journal of Biological Chemistry.

[23]  C. Higgins,et al.  Three-dimensional Structures of the Mammalian Multidrug Resistance P-glycoprotein Demonstrate Major Conformational Changes in the Transmembrane Domains upon Nucleotide Binding* , 2003, The Journal of Biological Chemistry.

[24]  D. D. de Alwis,et al.  Considerations in the design and development of transport inhibitors as adjuncts to drug therapy. , 2003, Advanced drug delivery reviews.

[25]  D. Clarke,et al.  Location of the Rhodamine-binding Site in the Human Multidrug Resistance P-glycoprotein* , 2002, The Journal of Biological Chemistry.

[26]  C. Hrycyna,et al.  Multidrug resistance and cancer: the role of the human ABC transporter ABCG2. , 2002, Current protein & peptide science.

[27]  E. Wang,et al.  Interaction of Common Azole Antifungals with P Glycoprotein , 2002, Antimicrobial Agents and Chemotherapy.

[28]  K. Linton,et al.  The xyz of ABC Transporters , 2001, Science.

[29]  A. Holzenburg,et al.  The Structure of the Multidrug Resistance Protein 1 (MRP1/ABCC1) , 2001, The Journal of Biological Chemistry.

[30]  E. Dassa,et al.  The ABC of ABCS: a phylogenetic and functional classification of ABC systems in living organisms. , 2001, Research in microbiology.

[31]  A. Rzhetsky,et al.  The human ATP-binding cassette (ABC) transporter superfamily. , 2001, Genome research.

[32]  Structural biology. The xyz of ABC transporters. , 2001, Science.

[33]  D. Keppler,et al.  The Multidrug Resistance Protein 5 Functions as an ATP-dependent Export Pump for Cyclic Nucleotides* , 2000, The Journal of Biological Chemistry.

[34]  M. Kool,et al.  A family of drug transporters: the multidrug resistance-associated proteins. , 2000, Journal of the National Cancer Institute.

[35]  M. Saier.  A Functional-Phylogenetic Classification System for Transmembrane Solute Transporters , 2000, Microbiology and Molecular Biology Reviews.

[36]  T. N. Bhat,et al.  The Protein Data Bank , 2000, Nucleic Acids Res..

[37]  Rolf Apweiler,et al.  The SWISS-PROT protein sequence database and its supplement TrEMBL in 2000 , 2000, Nucleic Acids Res..

[38]  M. Kool,et al.  The multidrug resistance protein family. , 1999, Biochimica et biophysica acta.

[39]  Multiple recognition of various amphiphilic molecules by the multidrug resistance P-glycoprotein: molecular mechanisms and pharmacological consequences coming from functional interactions between various drugs. , 1999, Anticancer research.

[40]  Richard Bonneau,et al.  Ab initio protein structure prediction of CASP III targets using ROSETTA , 1999, Proteins.

[41]  Claire O'Donovan,et al.  The SWISS-PROT protein sequence data bank and its supplement TrEMBL in 1999 , 1999, Nucleic Acids Res..

[42]  D. Meijer,et al.  Interactions between P‐glycoprotein substrates and other cationic drugs at the hepatic excretory level , 1998, British journal of pharmacology.

[43]  H. Kaback,et al.  From membrane to molecule to the third amino acid from the left with a membrane transport protein , 1997, Quarterly Reviews of Biophysics.

[44]  Retraction Kiehntopf,et al.  Retraction , 1997, Concurr. Comput. Pract. Exp..

[45]  D. Gadsby,et al.  ATP hydrolysis cycles and mechanism in P-glycoprotein and CFTR. , 1997, Seminars in cancer biology.

[46]  C. Higgins,et al.  Structure of the Multidrug Resistance P-glycoprotein to 2.5 nm Resolution Determined by Electron Microscopy and Image Analysis* , 1997, The Journal of Biological Chemistry.

[47]  Rolf Apweiler,et al.  The SWISS-PROT protein sequence data bank and its supplement TrEMBL , 1997, Nucleic Acids Res..

[48]  C. Sander,et al.  Errors in protein structures , 1996, Nature.

[49]  B. Rost.  PHD: predicting one-dimensional protein structure by profile-based neural networks. , 1996, Methods in enzymology.

[50]  Ruben Abagyan,et al.  ICM—A new method for protein modeling and design: Applications to docking and structure prediction from the distorted native conformation , 1994, J. Comput. Chem..

[51]  D. Keppler,et al.  ATP‐dependent transport of amphiphilic cations across the hepatocyte canalicular membrane mediated by mdr1 P‐glycoprotein , 1994, FEBS letters.

[52]  H. Scheraga,et al.  Energy parameters in polypeptides. 10. Improved geometrical parameters and nonbonded interactions for use in the ECEPP/3 algorithm, with application to proline-containing peptides , 1994 .

[53]  R. Abagyan,et al.  Biased probability Monte Carlo conformational searches and electrostatic calculations for peptides and proteins. , 1994, Journal of molecular biology.

[54]  T. Yeates,et al.  Verification of protein structures: Patterns of nonbonded atomic interactions , 1993, Protein science : a publication of the Protein Society.

[55]  J. Thornton,et al.  PROCHECK: a program to check the stereochemical quality of protein structures , 1993 .

[56]  J Hoflack,et al.  Three-dimensional models of neurotransmitter G-binding protein-coupled receptors. , 1991, Molecular pharmacology.

[57]  N. Saitou,et al.  The neighbor-joining method: a new method for reconstructing phylogenetic trees. , 1987, Molecular biology and evolution.

[58]  G. Hammes.  Unifying concept for the coupling between ion pumping and ATP hydrolysis or synthesis. , 1982, Proceedings of the National Academy of Sciences of the United States of America.

[59]  J. Walker,et al.  Distantly related sequences in the alpha‐ and beta‐subunits of ATP synthase, myosin, kinases and other ATP‐requiring enzymes and a common nucleotide binding fold. , 1982, The EMBO journal.